327 related articles for article (PubMed ID: 1680714)
1. [3H]5-methyl-urapidil labels 5-HT1A receptors and alpha 1-adrenoceptors in the rat CNS. In vitro binding and autoradiographic studies.
Laporte AM; Schechter LE; Bolaños FJ; Vergé D; Hamon M; Gozlan H
Eur J Pharmacol; 1991 May; 198(1):59-67. PubMed ID: 1680714
[TBL] [Abstract][Full Text] [Related]
2. Urapidil analogues are potent ligands of the 5-HT1A receptor.
Gross G; Schüttler K; Xin X; Hanft G
J Cardiovasc Pharmacol; 1990; 15 Suppl 7():S8-16. PubMed ID: 1702491
[TBL] [Abstract][Full Text] [Related]
3. The selective 5-HT1A antagonist radioligand [3H]WAY 100635 labels both G-protein-coupled and free 5-HT1A receptors in rat brain membranes.
Gozlan H; Thibault S; Laporte AM; Lima L; Hamon M
Eur J Pharmacol; 1995 Jan; 288(2):173-86. PubMed ID: 7720779
[TBL] [Abstract][Full Text] [Related]
4. Subclassification of alpha 1-adrenoceptor recognition sites by urapidil derivatives and other selective antagonists.
Hanft G; Gross G
Br J Pharmacol; 1989 Jul; 97(3):691-700. PubMed ID: 2569345
[TBL] [Abstract][Full Text] [Related]
5. Urapidil and some analogues with hypotensive properties show high affinities for 5-hydroxytryptamine (5-HT) binding sites of the 5-HT1A subtype and for alpha 1-adrenoceptor binding sites.
Gross G; Hanft G; Kolassa N
Naunyn Schmiedebergs Arch Pharmacol; 1987 Dec; 336(6):597-601. PubMed ID: 2832770
[TBL] [Abstract][Full Text] [Related]
6. Heterogeneity of alpha 2-adrenoceptors in rat cortex but not human platelets can be defined by 8-OH-DPAT, RU 24969 and methysergide.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Mar; 99(3):481-6. PubMed ID: 1970497
[TBL] [Abstract][Full Text] [Related]
7. Stereoselective binding of niguldipine enantiomers to alpha 1A-adrenoceptors labeled with [3H]5-methyl-urapidil.
Graziadei I; Zernig G; Boer R; Glossman H
Eur J Pharmacol; 1989 Oct; 172(4-5):329-37. PubMed ID: 2555206
[TBL] [Abstract][Full Text] [Related]
8. Vasodilatation elicited by 5-HT1A receptor agonists in constant-pressure-perfused rat kidney is mediated by blockade of alpha 1A-adrenoceptors.
Eltze M; Boer R; Sanders KH; Kolassa N
Eur J Pharmacol; 1991 Sep; 202(1):33-44. PubMed ID: 1686254
[TBL] [Abstract][Full Text] [Related]
9. [3H]1-[2-(4-aminophenyl)ethyl]-4-(3-trifluoromethylphenyl)piperazine: a selective radioligand for 5-HT1A receptors in rat brain.
Ransom RW; Asarch KB; Shih JC
J Neurochem; 1986 Jan; 46(1):68-75. PubMed ID: 2933490
[TBL] [Abstract][Full Text] [Related]
10. 125I-Bolton-Hunter-8-methoxy-2-[N-propyl-N-propylamino]tetralin as a new selective radioligand of 5-HT1A sites in the rat brain. In vitro binding and autoradiographic studies.
Gozlan H; Ponchant M; Daval G; Verge D; Menard F; Vanhove A; Beaucourt JP; Hamon M
J Pharmacol Exp Ther; 1988 Feb; 244(2):751-9. PubMed ID: 2964524
[TBL] [Abstract][Full Text] [Related]
11. Central 5-HT1A receptors and the mechanism of the central hypotensive effect of (+)8-OH-DPAT, DP-5-CT, R28935, and urapidil.
Doods HN; Boddeke HW; Kalkman HO; Hoyer D; Mathy MJ; van Zwieten PA
J Cardiovasc Pharmacol; 1988 Apr; 11(4):432-7. PubMed ID: 2453746
[TBL] [Abstract][Full Text] [Related]
12. Molecular pharmacology of 5-HT1 and 5-HT2 recognition sites in rat and pig brain membranes: radioligand binding studies with [3H]5-HT, [3H]8-OH-DPAT, (-)[125I]iodocyanopindolol, [3H]mesulergine and [3H]ketanserin.
Hoyer D; Engel G; Kalkman HO
Eur J Pharmacol; 1985 Nov; 118(1-2):13-23. PubMed ID: 2935410
[TBL] [Abstract][Full Text] [Related]
13. Alpha 2-adrenoceptor subtypes and imidazoline-like binding sites in the rat brain.
Brown CM; MacKinnon AC; McGrath JC; Spedding M; Kilpatrick AT
Br J Pharmacol; 1990 Apr; 99(4):803-9. PubMed ID: 1972896
[TBL] [Abstract][Full Text] [Related]
14. Involvement of brain 5-HT1A receptors in the hypotensive response to urapidil.
Kolassa N; Beller KD; Sanders KH
Am J Cardiol; 1989 Aug; 64(7):7D-10D. PubMed ID: 2569265
[TBL] [Abstract][Full Text] [Related]
15. [3H]WB4101 labels the 5-HT1A serotonin receptor subtype in rat brain. Guanine nucleotide and divalent cation sensitivity.
Norman AB; Battaglia G; Creese I
Mol Pharmacol; 1985 Dec; 28(6):487-94. PubMed ID: 2867462
[TBL] [Abstract][Full Text] [Related]
16. Differential cardiovascular effects of 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT), flesinoxan, 5-methyl-urapidil and MDL 75,608A in conscious spontaneously hypertensive rats.
Buisson-Defferier S; Hibert M; van den Buuse M
Fundam Clin Pharmacol; 1993; 7(9):499-511. PubMed ID: 7906241
[TBL] [Abstract][Full Text] [Related]
17. Interactions of lesopitron (E-4424) with central 5-HT1A receptors: in vitro and in vivo studies in the rat.
Haj-Dahmane S; Jolas T; Laporte AM; Gozlan H; Farré AJ; Hamon M; Lanfumey L
Eur J Pharmacol; 1994 Apr; 255(1-3):185-96. PubMed ID: 8026543
[TBL] [Abstract][Full Text] [Related]
18. Autoradiographic localization and pharmacological characterization of [3H]tandospirone binding sites in the rat brain.
Tanaka H; Shimizu H; Kumasaka Y; Hirose A; Tatsuno T; Nakamura M
Brain Res; 1991 Apr; 546(2):181-9. PubMed ID: 1648988
[TBL] [Abstract][Full Text] [Related]
19. NAN-190: agonist and antagonist interactions with brain 5-HT1A receptors.
Rydelek-Fitzgerald L; Teitler M; Fletcher PW; Ismaiel AM; Glennon RA
Brain Res; 1990 Nov; 532(1-2):191-6. PubMed ID: 2282513
[TBL] [Abstract][Full Text] [Related]
20. Differentiation of pre- and post-synaptic high affinity serotonin receptor binding sites using physico-chemical parameters and modifying agents.
Hall MD; Gozlan H; Emerit MB; el Mestikawy S; Pichat L; Hamon M
Neurochem Res; 1986 Jun; 11(6):891-912. PubMed ID: 3016581
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
